EDGE
Book a demo

All Updates

Filter
This week:
Earnings/results
Erasca misses analyst expectations; net losses widen for Q4 and 2022
AI Drug Discovery
Mar 23
Earnings/results
Exscientia misses analyst estimate; losses deepen
AI Drug Discovery
Mar 23
Partnerships
Dewpoint Therapeutics partners with Novo Nordisk to treat insulin resistance and diabetic complications
AI Drug Discovery
Mar 22
Partnerships
AbCellera and RQ Bio partner to identify antibodies for infectious diseases
AI Drug Discovery
Mar 22
M&A
Berkeley Lights completes IsoPlexis Corporation acquisition
AI Drug Discovery
Mar 21
Last week:
Partnerships
Zephyr AI partners with KangarooHealth to combine AI and RPM
AI Drug Discovery
Mar 16
Funding
Protai raises additional USD 12 million in seed funding
AI Drug Discovery
Mar 15
Partnerships
Rune Labs partners with BlueRock Therapeutics to carry out clinical studies for Parkinson’s disease
AI Drug Discovery
Mar 14
Product updates
Exscientia expands its precision oncology pipeline
AI Drug Discovery
Mar 14
Partnerships
Paige expands partnership with Leica Biosystems for AI-powered pathology workflow solutions
AI Drug Discovery
Mar 13
Funding
Iktos raises EUR 15.5 million in Series A funding
AI Drug Discovery
Mar 9
Partnerships
Exscientia partners with Charité to develop precision medicine platform
AI Drug Discovery
Mar 7
Funding
Congruence Therapeutics raises USD 15 million in extended Series A
AI Drug Discovery
Mar 6
M&A
Lantern Pharma forms new subsidiary, Starlight Therapeutics, to focus on CNS and brain cancer treatments
AI Drug Discovery
Mar 6
Funding
Antiverse raises GBP 2.5 million; identifies eight therapeutic antibodies
AI Drug Discovery
Mar 2
Funding
TandemAI raises USD 35 million in Series A
AI Drug Discovery
Mar 1
Earnings/results
Relay Therapeutics beats EPS analyst estimates in FY2022
AI Drug Discovery
Feb 23
Funding
Mydecine raises USD 0.7 million in the eighth tranche of common share subscription agreement
AI Drug Discovery
Feb 23
Partnerships
Zephyr AI partners with M2GEN to develop novel cancer treatments
AI Drug Discovery
Feb 16
Funding
Hexagon Bio raises USD 77.3 million Series B
AI Drug Discovery
Feb 13
M&A
Takeda acquires Nimbus Therapeutics’s subsidiary; pays USD 4 billion upfront
AI Drug Discovery
Feb 9
Partnerships
ReviR Therapeutics partners with Asieris Pharmaceuticals to develop novel oncology therapies
AI Drug Discovery
Feb 8
Funding
Alto Neuroscience raises USD 60 million in Series B and debt financing
AI Drug Discovery
Jan 30
Funding
Atomic AI emerges from stealth with USD 35 million in Series A
AI Drug Discovery
Jan 25
Partnerships
CytoReason and Sanofi extend multi-million dollar AI deal to develop IBD therapies
AI Drug Discovery
Jan 23
Partnerships
Arbor Biotechnologies and Vertex Pharmaceuticals partner to develop genetic medicines
AI Drug Discovery
Jan 17
Funding
Parallel Bio raises USD 4.3 million in a seed funding round
AI Drug Discovery
Dec 21, 2022
Funding
Quris raises an additional USD 9 million in seed funding
AI Drug Discovery
Dec 20, 2022
Partnerships
Cyclica partners with SK Chemicals to develop novel therapeutics
AI Drug Discovery
Dec 13, 2022
Funding
Management news
Komodo Health raises USD 200 million in equity capital; lays off 9% of workforce
AI Drug Discovery
Dec 13, 2022
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.